Open AccessNeutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
Author(s) -
Kabsoo Shin,
Eunkyo Jung,
Sejun Park,
Seok–Hwan Jeong,
Inho Kim,
Myung Ah Lee
Publication year - 2021
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v13.i8.915
Subject(s) - medicine , chemotherapy , neutrophil to lymphocyte ratio , lymphocyte , pancreatic cancer , oncology , antigen , immunology , cancer , gastroenterology
A decline in serum carbohydrate antigen 19-9 (CA19-9) levels during systemic chemotherapy is considered as a prognostic marker for patients with advanced pancreatic cancer. Neutrophil-to-lymphocyte ratio (NLR) has been extensively studied as a simple and useful indicator of prognosis in various cancers including pancreatic cancer.